Palliative Care in High-Grade Glioma: A Review
High-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial suppor...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-10-01
|
| Series: | Brain Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3425/10/10/723 |
| _version_ | 1797551226421772288 |
|---|---|
| author | Rita C. Crooms Nathan E. Goldstein Eli L. Diamond Barbara G. Vickrey |
| author_facet | Rita C. Crooms Nathan E. Goldstein Eli L. Diamond Barbara G. Vickrey |
| author_sort | Rita C. Crooms |
| collection | DOAJ |
| description | High-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial support, which can be delivered concurrently with cancer-directed treatments. In this article, we review palliative care needs associated with HGG and identify opportunities for primary and specialty palliative care interventions. Patients with HGG and their caregivers experience high levels of distress due to physical, emotional, and cognitive symptoms that negatively impact quality of life and functional independence, all in the context of limited life expectancy. However, patients typically have limited contact with specialty palliative care until the end of life, and there is no established model for ensuring their palliative care needs are met throughout the disease course. We identify low rates of advance care planning, misconceptions about palliative care being synonymous with end-of-life care, and the unique neurologic needs of this patient population as some of the potential barriers to increased palliative interventions. Further research is needed to define the optimal roles of neuro-oncologists and palliative care specialists in the management of this illness and to establish appropriate timing and models for palliative care delivery. |
| first_indexed | 2024-03-10T15:41:32Z |
| format | Article |
| id | doaj.art-83a4dbccea524e539b99a10fbdbe9b3e |
| institution | Directory Open Access Journal |
| issn | 2076-3425 |
| language | English |
| last_indexed | 2024-03-10T15:41:32Z |
| publishDate | 2020-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Brain Sciences |
| spelling | doaj.art-83a4dbccea524e539b99a10fbdbe9b3e2023-11-20T16:49:57ZengMDPI AGBrain Sciences2076-34252020-10-01101072310.3390/brainsci10100723Palliative Care in High-Grade Glioma: A ReviewRita C. Crooms0Nathan E. Goldstein1Eli L. Diamond2Barbara G. Vickrey3Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USAIcahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USADepartment of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USAIcahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USAHigh-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial support, which can be delivered concurrently with cancer-directed treatments. In this article, we review palliative care needs associated with HGG and identify opportunities for primary and specialty palliative care interventions. Patients with HGG and their caregivers experience high levels of distress due to physical, emotional, and cognitive symptoms that negatively impact quality of life and functional independence, all in the context of limited life expectancy. However, patients typically have limited contact with specialty palliative care until the end of life, and there is no established model for ensuring their palliative care needs are met throughout the disease course. We identify low rates of advance care planning, misconceptions about palliative care being synonymous with end-of-life care, and the unique neurologic needs of this patient population as some of the potential barriers to increased palliative interventions. Further research is needed to define the optimal roles of neuro-oncologists and palliative care specialists in the management of this illness and to establish appropriate timing and models for palliative care delivery.https://www.mdpi.com/2076-3425/10/10/723palliative caresupportive caregliomaquality of life |
| spellingShingle | Rita C. Crooms Nathan E. Goldstein Eli L. Diamond Barbara G. Vickrey Palliative Care in High-Grade Glioma: A Review Brain Sciences palliative care supportive care glioma quality of life |
| title | Palliative Care in High-Grade Glioma: A Review |
| title_full | Palliative Care in High-Grade Glioma: A Review |
| title_fullStr | Palliative Care in High-Grade Glioma: A Review |
| title_full_unstemmed | Palliative Care in High-Grade Glioma: A Review |
| title_short | Palliative Care in High-Grade Glioma: A Review |
| title_sort | palliative care in high grade glioma a review |
| topic | palliative care supportive care glioma quality of life |
| url | https://www.mdpi.com/2076-3425/10/10/723 |
| work_keys_str_mv | AT ritaccrooms palliativecareinhighgradegliomaareview AT nathanegoldstein palliativecareinhighgradegliomaareview AT elildiamond palliativecareinhighgradegliomaareview AT barbaragvickrey palliativecareinhighgradegliomaareview |